Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Amendola

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
La Medicina Del Lavoro|April 26, 2005
[A monitoring system for occupational cancer]P Crosignani, M Nesti, R Audisio, et al.
Revista Brasileira De Terapia Intensiva|October 14, 2014
[Cancer disease should not be a limitative factor for admission of high risk surgical patients to an intensive care unit]Cristina P Amendola, Samantha L S Almeida, Vanessa M Horta, et al.
Critical Care (London, England)|July 11, 2025
Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trialFernando G Zampieri, Luciano C P Azevedo, Ary Serpa Neto, et al.
JACC. Advances|December 20, 2025
Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER TrialCaio A M Tavares, Luciano C P Azevedo, Patrícia O Guimarães, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
Annals of Intensive Care|April 26, 2023
Attributable mortality due to nosocomial sepsis in Brazilian hospitals: a case-control studyFernando G Zampieri, Alexandre B Cavalcanti, Leandro U Taniguchi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
La Medicina Del Lavoro|April 26, 2005
[A monitoring system for occupational cancer]P Crosignani, M Nesti, R Audisio, et al.
Revista Brasileira De Terapia Intensiva|October 14, 2014
[Cancer disease should not be a limitative factor for admission of high risk surgical patients to an intensive care unit]Cristina P Amendola, Samantha L S Almeida, Vanessa M Horta, et al.
Critical Care (London, England)|July 11, 2025
Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trialFernando G Zampieri, Luciano C P Azevedo, Ary Serpa Neto, et al.
JACC. Advances|December 20, 2025
Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER TrialCaio A M Tavares, Luciano C P Azevedo, Patrícia O Guimarães, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
Annals of Intensive Care|April 26, 2023
Attributable mortality due to nosocomial sepsis in Brazilian hospitals: a case-control studyFernando G Zampieri, Alexandre B Cavalcanti, Leandro U Taniguchi, et al.
Pageof 2